Health

FDA Panel to Weigh Grail’s Galleri Test

Updated 2026-08-10 14:55 UTC 1 source Neutral

An FDA panel is set to weigh the merits of Grail's Galleri test, a cancer screening tool. The meeting includes discussions on China's biotech innovation and radiopharma challenges.

Coverage timeline — 1 article

STAT News

STAT+: FDA panel to weigh Grail’s Galleri test

China reins in its biotech innovation engine, radiopharma boom meets unexpected hurdles, and more news from The Readout

2026-08-10 14:48 UTC